PD-L1 ANTIBODY MOLECULES AND THEIR USES
MA40035AUndetermined Publication Date: 2016-04-21DANA FARBER CANCER INSTITUTE INC +2
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40035
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-09-01
- Filing Date
- 2015-10-13
- Publication Date
- 2016-04-21
Abstract
Antibody molecules that bind specifically to pd-1ll are described. Combination therapies including anti-pd-1ll antibody molecules are also described. Anti-pd-1ll antibody molecules can be used to treat, prevent, and / or diagnose cancerous or infectious conditions and disorders.
Need to check novelty before this filing date? Find Prior Art